A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) ...

Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced it received FDA clearance for the Android version of its mobile app Tandem Mobi. The system, powered by Control-IQ ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...

Abstract: This paper designs a control system for a five-axis tandem robot based on the ROS framework. The controller adopts a multi-core control mode, and the complex computation and real-time ...

The t:slim X2 insulin pump is a small, tubed pump with a color touchscreen. Users can control the pump directly from the device or using an iPhone or Android smartphone app. The t:slim X2 is part of ...

The Mobi miniature, durable automated insulin patch pump worn on a hiker’s leg. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it ...

CEO John Sheridan highlighted that Tandem achieved over 20% growth for the third consecutive quarter, with record sales both in the U.S. and internationally. The company's operational focus on ...

Among pediatric patients with T1D, 90-day time in range was similar between those who used the Insulet Omnipod 5 or the Tandem Control IQ. US youth with type 1 diabetes (T1D) who use the 2 most common ...

Tandem Diabetes Care Inc.’s Control-IQ+ automated insulin delivery system improved multiple measures of glycemic control in individuals with type 2 diabetes who use insulin, a study presented March 19 ...

Tandem Diabetes Care Inc.’s Control-IQ+ automated insulin delivery system improved multiple measures of glycemic control in individuals with type 2 diabetes who use insulin, a study presented March 19 ...